Tecan Group Ltd (TECN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tecan Group Ltd (TECN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9929
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tecan Group Ltd (Tecan) is a provider of automated laboratory instruments and solutions for use in basic and translational research, clinical diagnostics, and drug discovery. The company develops, manufactures, and markets automated workflow solutions for laboratories and instrumentation suppliers. Its product portfolio encompasses liquid handling and robotics, reader and washer, microarray products, components, software, and consumables. Tecan’s products find applications in agriculture, forensic solutions, analytical chemistry, cell biology, drug discovery, genomic solutions, protein science solutions, ELISA solutions and synthetic biology. The company has manufacturing facilities, and research and development facilities in Europe and North America. Tecan is headquartered in Mannedorf, Zurich, Switzerland.

Tecan Group Ltd (TECN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tecan Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tecan Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 11
Tecan Enters Into Co-Promotion Agreement With JPT Peptide Technologies For Array Products 12
Acquisition 13
Tecan Group Acquires NuGEN Technologies for USD54.5 Million 13
Tecan Group Ltd – Key Competitors 14
Tecan Group Ltd – Key Employees 15
Tecan Group Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Financial Announcements 18
Aug 16, 2018: H1 2018: Tecan posts strong increase in sales, driven by growth in the Partnering Business 18
Aug 16, 2018: Tecan: Financial results for the first half of 2018 21
Aug 16, 2018: Tecan posts strong increase in sales, driven by growth in the Partnering Business 24
Aug 16, 2017: H1 2017: Tecan with significant increase in order entry and strong sales growth in the Life Sciences Business 27
Mar 15, 2017: Full year 2016: Another year of double-digit sales growth for Tecan 30
Corporate Communications 33
Oct 06, 2017: Tecan initiates succession process for the Board of Directors 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Tecan Group Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tecan Group Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tecan Group Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Tecan Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tecan Group Enters Into Co-Marketing Agreement With TAP Biosystem For RAFT System 11
Tecan Enters Into Co-Promotion Agreement With JPT Peptide Technologies For Array Products 12
Tecan Group Acquires NuGEN Technologies for USD54.5 Million 13
Tecan Group Ltd, Key Competitors 14
Tecan Group Ltd, Key Employees 15
Tecan Group Ltd, Subsidiaries 16

List of Figures
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tecan Group Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tecan Group Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Tecan Group Ltd (TECN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alleghany Corporation:戦略・SWOT・企業財務分析
    Alleghany Corporation - Strategy, SWOT and Corporate Finance Report Summary Alleghany Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sino-U.S. United Metlife Insurance Co., Ltd.:企業の戦略・SWOT・財務分析
    Sino-U.S. United Metlife Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sino-U.S. United Metlife Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • TransGlobe Energy Corp (TGL):企業の財務・戦略的SWOT分析
    Summary TransGlobe Energy Corp (TransGlobe Energy) is an oil and gas company that explores, develops and produces crude oil and natural gas. The company develops oil and natural gas properties in the Arab Republic of Egypt and the Republic of Yemen. It holds interests in various production sharing c …
  • ECA S.A.:企業の戦略・SWOT・財務情報
    ECA S.A. - Strategy, SWOT and Corporate Finance Report Summary ECA S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Erbud SA:企業の戦略・SWOT・財務情報
    Erbud SA - Strategy, SWOT and Corporate Finance Report Summary Erbud SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Jacobs Engineering Group Inc (JEC):企業の財務・戦略的SWOT分析
    Jacobs Engineering Group Inc (JEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Immunovia AB (IMMNOV):企業の財務・戦略的SWOT分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • Mallinckrodt, LLC-製薬・医療分野:企業M&A・提携分析
    Summary Mallinckrodt LLC (Mallinckrodt), a subsidiary of Mallinckrodt Plc is a biophramaceutical company that develops medicines. The company manufactures, markets and distributes generic and specialty pharmaceuticals, active pharmaceutical ingredients, diagnostic imaging agents, global medical imag …
  • Reliance Communications Ltd (RCOM):企業の財務・戦略的SWOT分析
    Reliance Communications Ltd (RCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Inova Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Inova Diagnostics Inc (Inova), a subsidiary of Werfen Life Group SAU is a medical device company that develops and commercializes new autoimmune technologies and diagnostic markers. The company's diagnostic reagent products include quanta flash used for semi-quantitative determination of aut …
  • The Kraft Heinz Co:企業の戦略・SWOT・財務情報
    The Kraft Heinz Co - Strategy, SWOT and Corporate Finance Report Summary The Kraft Heinz Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Rite Aid Corporation:企業の戦略・SWOT・財務分析
    Rite Aid Corporation - Strategy, SWOT and Corporate Finance Report Summary Rite Aid Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Enterprise Rent-A-Car Company:企業の戦略・SWOT・財務分析
    Enterprise Rent-A-Car Company - Strategy, SWOT and Corporate Finance Report Summary Enterprise Rent-A-Car Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cermaq Group AS:企業の戦略的SWOT分析
    Cermaq Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Aeon Delight Co Ltd:企業の戦略・SWOT・財務情報
    Aeon Delight Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Aeon Delight Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Claris Lifesciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company provides generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. It provides products are offered through various de …
  • Murata Manufacturing Co Ltd (6981):企業の財務・戦略的SWOT分析
    Murata Manufacturing Co Ltd (6981) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • eBay Inc:戦略・SWOT・企業財務分析
    eBay Inc - Strategy, SWOT and Corporate Finance Report Summary eBay Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Netflix Inc.:企業の戦略・SWOT・財務分析
    Netflix Inc. - Strategy, SWOT and Corporate Finance Report Summary Netflix Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Nippon Chemiphar Co Ltd (4539):企業の財務・戦略的SWOT分析
    Summary Nippon Chemiphar Co Ltd (Nippon Chemiphar) is a provider of pharmaceutical drugs and health-related services. The company manufactures, supplies, imports and exports ethical pharmaceuticals and diagnostic agents. Nippon Chemiphar offers diagnostic products, such as IgE NC, a diagnostic kit t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆